Ozakbas, S. Et Al. 2022. COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study. 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , (Amsterdam, Netherlands), 764-765.

Ozakbas, S., Baba, C., ÖZÇELİK, S., Özdoğar, A. T., KAYA, E., DOĞAN, Y., ... ÇEVİK, S.(2022). COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study . 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (pp.764-765). Amsterdam, Netherlands

Ozakbas, SERKAN Et Al. "COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study," 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 2022

Ozakbas, SERKAN Et Al. "COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, pp.764-765, 2022

Ozakbas, S. Et Al. (2022) . "COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, pp.764-765.

@conferencepaper{conferencepaper, author={SERKAN ÖZAKBAŞ Et Al. }, title={COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study}, congress name={38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis}, city={Amsterdam}, country={Netherlands}, year={2022}, pages={764-765} }